These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9496334)
1. Clinical significance of cytogenetic abnormalities in uterine myomas. Brosens I; Deprest J; Dal Cin P; Van den Berghe H Fertil Steril; 1998 Feb; 69(2):232-5. PubMed ID: 9496334 [TBL] [Abstract][Full Text] [Related]
2. Cytogenetic abnormalities in uterine myomas are associated with myoma size. Rein MS; Powell WL; Walters FC; Weremowicz S; Cantor RM; Barbieri RL; Morton CC Mol Hum Reprod; 1998 Jan; 4(1):83-6. PubMed ID: 9510016 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the karyotype and desoxyribonucleic acid content of uterine myomas in premenopausal, menopausal, and gonadotropin-releasing hormone agonist-treated females. Brosens I; Johannisson E; Dal Cin P; Deprest J; Van den Berghe H Fertil Steril; 1996 Sep; 66(3):376-9. PubMed ID: 8751732 [TBL] [Abstract][Full Text] [Related]
4. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study. Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912 [TBL] [Abstract][Full Text] [Related]
5. Cytogenetic aberrations and the development of uterine leiomyomata. El-Gharib MN; Elsobky ES J Obstet Gynaecol Res; 2010 Feb; 36(1):101-7. PubMed ID: 20178534 [TBL] [Abstract][Full Text] [Related]
6. Clonal chromosome rearrangements in a uterine myoma. Gibas Z; Griffin CA; Emanuel BS Cancer Genet Cytogenet; 1988 May; 32(1):19-24. PubMed ID: 3355997 [TBL] [Abstract][Full Text] [Related]
7. Cytogenetic analysis of uterine leiomyoma: the size, histopathology and GnRHa-response in relation to chromosome karyotype. Kataoka S; Yamada H; Hoshi N; Kudo M; Hareyama H; Sakuragi N; Fujimoto S Eur J Obstet Gynecol Reprod Biol; 2003 Sep; 110(1):58-62. PubMed ID: 12932873 [TBL] [Abstract][Full Text] [Related]
8. Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: results of a multicentre, randomised controlled trial. Vercellini P; Crosignani PG; Mangioni C; Imparato E; Ferrari A; De Giorgi O Br J Obstet Gynaecol; 1998 Nov; 105(11):1148-54. PubMed ID: 9853762 [TBL] [Abstract][Full Text] [Related]
9. Laparoscopic myomectomy: do size, number, and location of the myomas form limiting factors for laparoscopic myomectomy? Sinha R; Hegde A; Mahajan C; Dubey N; Sundaram M J Minim Invasive Gynecol; 2008; 15(3):292-300. PubMed ID: 18439500 [TBL] [Abstract][Full Text] [Related]
11. Medical treatment of uterine myoma with long-acting gonadotropin-releasing hormone agonist prior to myomectomy. Liu CH; Lin YS; Lin CC; Tzeng CC; Chou CY J Formos Med Assoc; 1993 Jun; 92(6):536-9. PubMed ID: 8106041 [TBL] [Abstract][Full Text] [Related]
12. Cytogenetic abnormalities in uterine leiomyomata. Rein MS; Friedman AJ; Barbieri RL; Pavelka K; Fletcher JA; Morton CC Obstet Gynecol; 1991 Jun; 77(6):923-6. PubMed ID: 2030869 [TBL] [Abstract][Full Text] [Related]
13. Quantitative MRI of uterine leiomyomas during triptorelin treatment: reproducibility of volume assessment and predictability of treatment response. Broekmans FJ; Heitbrink MA; Hompes PG; Schoute E; Falke T; Schoemaker J Magn Reson Imaging; 1996; 14(10):1127-35. PubMed ID: 9065902 [TBL] [Abstract][Full Text] [Related]
14. GnRH agonist treatment before total laparoscopic hysterectomy for large uteri. Seracchioli R; Venturoli S; Colombo FM; Bagnoli A; Vianello F; Govoni F; Guerrini M; Gualerzi B J Am Assoc Gynecol Laparosc; 2003 Aug; 10(3):316-9. PubMed ID: 14567804 [TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657 [TBL] [Abstract][Full Text] [Related]
16. Hysteroscopic Myomectomy of Large Submucous Myomas in a 1-Step Procedure Using Multiple Slicing Sessions Technique. Zayed M; Fouda UM; Zayed SM; Elsetohy KA; Hashem AT J Minim Invasive Gynecol; 2015; 22(7):1196-202. PubMed ID: 26093183 [TBL] [Abstract][Full Text] [Related]
17. The application of GnRH analogues in the treatment of uterine myomas in perimenopausal women. Dragojević-Dikić S; Vućić M Ginekol Pol; 1998 Jan; 69(1):28-33. PubMed ID: 9553319 [TBL] [Abstract][Full Text] [Related]
18. Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study. Ferrero S; Alessandri F; Vellone VG; Venturini PL; Leone Roberti Maggiore U Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():43-7. PubMed ID: 27566221 [TBL] [Abstract][Full Text] [Related]
19. Unsuspected uterine leiomyosarcoma discovered during treatment with a gonadotropin-releasing hormone analogue: a case report and literature review. Milman D; Zalel Y; Biran H; Open M; Caspi B; Hagay Z; Dgani R Eur J Obstet Gynecol Reprod Biol; 1998 Feb; 76(2):237-40. PubMed ID: 9481582 [TBL] [Abstract][Full Text] [Related]
20. Long term effects of Tibolone on postmenopausal women with uterine myomas. Gregoriou O; Konidaris S; Botsis D; Papadias C; Makrakis E; Creatsas G Maturitas; 2001 Oct; 40(1):95-9. PubMed ID: 11684378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]